您的位置: 首页 > 农业专利 > 详情页

Relevance of achieved levels of markers of systemic inflammation following treatment
专利权人:
THE BRIGHAM AND WOMEN'S HOSPITAL; INC.;THE BRIGHAM AND WOMENSS HOSPITAL
发明人:
RIDKER, PAUL M.
申请号:
AU2005294165
公开号:
AU2005294165B2
申请日:
2005.10.06
申请国别(地区):
AU
年份:
2012
代理人:
摘要:
The invention involves, inter alia, the use of markers of systemic inflammation to determine whether or not an individual undergoing treatment with a cardiovascular agent to reduce the risk of a future cardiovascular event will benefit from continued treatment with the cardiovascular agent. Further, this invention describes the use of markers of systemic inflammation to evaluate the efficacy of treatment and to assist physicians in deciding on the course of a treatment in an individual at risk of future cardiovascular events.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充